OTOP1
gene geneOn this page
Summary
OTOP1 (otopetrin 1, HGNC:19656) is a protein-coding gene on chromosome 4p16.3, encoding Proton channel OTOP1 (Q7RTM1). Proton-selective ion channel. It is a selective cancer dependency (DepMap: 32.6% of cell lines).
This gene encodes a transmembrane protein which belongs to the otopetrin domain protein family and is required for the formation of otoconia and otoliths, calcium carbonate biominerals within the inner ear of mammals that are required for the detection of linear acceleration and gravity. This gene modulates purinergic control of intracellular calcium in vestibular supporting cells. Naturally occurring mutations in the orthologous mouse gene are associated with nonsyndromic otoconia agenesis and a consequent balance defect. The orthologous mouse gene is also induced in white adipose tissue during obesity. The encoded protein is a component of a counterinflammatory pathway that attenuates obesity-induced adipose tissue inflammation and plays an adaptive role in maintaining metabolic homeostasis in obesity.
Source: NCBI Gene 133060 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 120 total — 1 pathogenic
- Cancer dependency (DepMap): dependent in 32.6% of screened cell lines
- MANE Select transcript:
NM_177998
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:19656 |
| Approved symbol | OTOP1 |
| Name | otopetrin 1 |
| Location | 4p16.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000163982 |
| Ensembl biotype | protein_coding |
| OMIM | 607806 |
| Entrez | 133060 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000296358
RefSeq mRNA: 1 — MANE Select: NM_177998
NM_177998
CCDS: CCDS3372
Canonical transcript exons
ENST00000296358 — 6 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001080243 | 4202448 | 4202578 |
| ENSE00001080246 | 4226462 | 4226929 |
| ENSE00001080248 | 4206072 | 4206130 |
| ENSE00001080249 | 4197166 | 4198103 |
| ENSE00001080250 | 4212868 | 4213004 |
| ENSE00001531002 | 4188726 | 4188973 |
Expression profiles
Bgee: expression breadth broad, 11 present calls, max score 74.78.
Top tissues by expression
127 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 74.78 | silver quality |
| colonic epithelium | UBERON:0000397 | 42.10 | gold quality |
| skin of abdomen | UBERON:0001416 | 40.96 | gold quality |
| zone of skin | UBERON:0000014 | 40.51 | gold quality |
| skin of leg | UBERON:0001511 | 40.02 | gold quality |
| stromal cell of endometrium | CL:0002255 | 39.81 | gold quality |
| esophagus mucosa | UBERON:0002469 | 39.25 | silver quality |
| bone marrow cell | CL:0002092 | 38.05 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 37.68 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| sural nerve | UBERON:0015488 | 36.22 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| granulocyte | CL:0000094 | 35.06 | gold quality |
| mucosa of stomach | UBERON:0001199 | 33.47 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 33.38 | gold quality |
| vagina | UBERON:0000996 | 32.86 | silver quality |
| bone marrow | UBERON:0002371 | 32.71 | gold quality |
| left uterine tube | UBERON:0001303 | 32.16 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 31.95 | gold quality |
| esophagus | UBERON:0001043 | 31.54 | gold quality |
| muscle tissue | UBERON:0002385 | 31.06 | gold quality |
| prefrontal cortex | UBERON:0000451 | 30.34 | gold quality |
| primary visual cortex | UBERON:0002436 | 30.24 | gold quality |
| liver | UBERON:0002107 | 29.07 | gold quality |
| tonsil | UBERON:0002372 | 28.55 | gold quality |
| leukocyte | CL:0000738 | 28.25 | gold quality |
| duodenum | UBERON:0002114 | 28.14 | gold quality |
| monocyte | CL:0000576 | 27.76 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.80 |
Regulation
Is transcription factor: no
Functional genomics
DepMap (CRISPR cell-line fitness): dependent in 32.6% of screened cell lines.
Literature-anchored findings (GeneRIF, showing 1)
- The roles of two extracellular loops in proton sensing and permeation in human Otop1 proton channel. (PMID:36266567)
Cross-species orthologs
9 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | OTOP1 | ENSDARG00000021566 |
| mus_musculus | Otop1 | ENSMUSG00000051596 |
| rattus_norvegicus | Otop1 | ENSRNOG00000028423 |
| caenorhabditis_elegans | WBGENE00010403 | |
| caenorhabditis_elegans | WBGENE00017034 | |
| caenorhabditis_elegans | WBGENE00017449 | |
| caenorhabditis_elegans | WBGENE00018478 | |
| caenorhabditis_elegans | WBGENE00018479 | |
| caenorhabditis_elegans | WBGENE00018480 |
Paralogs (2): OTOP3 (ENSG00000182938), OTOP2 (ENSG00000183034)
Protein
Protein identifiers
Proton channel OTOP1 — Q7RTM1 (reviewed: Q7RTM1)
Alternative names: Otopetrin-1
All UniProt accessions (1): Q7RTM1
UniProt curated annotations — full annotation on UniProt →
Function. Proton-selective ion channel. Biphasically modulated by acid and alkali, mediating proton influx and efflux in response to extracellular acid and base stimulation, respectively. Sour taste receptor, which carries inward currents in response to extracellular acidification. Sensor for ammonium chloride (NH(4)Cl) in taste receptor cells. NH(4)Cl acts by increasing the intracellular pH, thereby generating a driving force for proton entry through OTOP1 channel. Might also participate in alkaline sensation. Plays a role in the regulation of Ca(2+) flux in response to purigenic (ATP, ADP and UDP) stimuli, leading to increase in cytosolic Ca(2+) due to influx of extracellular calcium. May play this role by inhibiting P2Y purinoceptor-mediated Ca(2+) release in a Ca(2+)-dependent manner and promote an influx of Ca(2+) in response to ATP. Through this mechanism and possibly others, plays a role in the formation and function of calcium carbonate-based structures in the vestibular system of the inner ear, called otoconia, that sense gravity and linear acceleration. In obesity, may attenuate adipose tissue inflammation, through the negative regulation of IFNG signaling, hence may play an adaptive role in the maintainance of metabolic homeostasis. Following alkali activation, may also be permeable Na(+), K(+), Cs(+) and Li(+).
Subunit / interactions. Homodimer. Interacts with STAT1, independently of STAT1 phosphorylation status.
Subcellular location. Cell membrane. Cell projection. Microvillus.
Activity regulation. Activated by both acid and alkali, with proton influx in response to extracellular acid and proton efflux during alkali stimulation. Inhibited by Zn(2+); this inhibition is thought to be pH-sensitive. Currents evoked in response to mild acid (pH 6.0) stimulus may also be mildly potentiated by exposure to Zn(2+). Activated by NH(4)Cl.
Domain organisation. Residues involved in the gating by extracellular Zn (2+) and pH are located in the extracellular loops between transmembrane domain 5-6 and transmembrane domain 11-12.
Similarity. Belongs to the otopetrin family.
RefSeq proteins (1): NP_819056* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR004878 | Otopetrin | Family |
Pfam: PF03189
Catalyzed reactions (Rhea), 1 shown:
- H(+)(in) = H(+)(out) (RHEA:34979)
UniProt features (41 total): topological domain 13, transmembrane region 12, sequence variant 5, mutagenesis site 5, region of interest 2, compositionally biased region 2, chain 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q7RTM1-F1 | 76.44 | 0.40 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Mutagenesis-validated functional residues (5):
| Position | Phenotype |
|---|---|
| 229 | complete loss of h(+) current at ph 5 and 4.5. |
| 229 | abolishes proton channel activity at ph 5 and 4.5. |
| 570 | does not affect cell membrane localization. reduction of proton channel activity. |
| 570 | does not affect proton channel activity. |
| 570 | does not affect cell membrane localization. strong reduction of proton channel activity. |
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-9729555 | Sensory perception of sour taste |
MSigDB gene sets: 92 (showing top):
GOBP_RESPONSE_TO_NITROGEN_COMPOUND, BENPORATH_ES_WITH_H3K27ME3, GOBP_RESPONSE_TO_PEPTIDE, GOBP_NEGATIVE_REGULATION_OF_INNATE_IMMUNE_RESPONSE, GOBP_RESPONSE_TO_GRAVITY, GOBP_CELLULAR_RESPONSE_TO_OXYGEN_CONTAINING_COMPOUND, GOBP_CELLULAR_RESPONSE_TO_INSULIN_STIMULUS, GOBP_MONOATOMIC_CATION_TRANSPORT, GOBP_NEGATIVE_REGULATION_OF_RESPONSE_TO_BIOTIC_STIMULUS, GOBP_ANIMAL_ORGAN_MORPHOGENESIS, GOBP_REGULATION_OF_IMMUNE_RESPONSE, GOBP_EAR_DEVELOPMENT, GOBP_DEFENSE_RESPONSE_TO_OTHER_ORGANISM, GOBP_CELLULAR_RESPONSE_TO_HORMONE_STIMULUS, GOBP_RESPONSE_TO_INSULIN
GO Biological Process (10): detection of gravity (GO:0009590), otolith formation (GO:0032475), cellular response to insulin stimulus (GO:0032869), otolith mineralization (GO:0045299), negative regulation of type II interferon-mediated signaling pathway (GO:0060336), proton transmembrane transport (GO:1902600), monoatomic ion transport (GO:0006811), biomineral tissue development (GO:0031214), monoatomic ion transmembrane transport (GO:0034220), inner ear morphogenesis (GO:0042472)
GO Molecular Function (2): proton channel activity (GO:0015252), identical protein binding (GO:0042802)
GO Cellular Component (4): plasma membrane (GO:0005886), microvillus (GO:0005902), membrane (GO:0016020), cell projection (GO:0042995)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Sensory perception of taste | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 2 |
| detection of external stimulus | 1 |
| detection of abiotic stimulus | 1 |
| response to gravity | 1 |
| otolith morphogenesis | 1 |
| anatomical structure formation involved in morphogenesis | 1 |
| response to insulin | 1 |
| cellular response to peptide hormone stimulus | 1 |
| biomineral tissue development | 1 |
| otolith development | 1 |
| negative regulation of cytokine-mediated signaling pathway | 1 |
| negative regulation of response to type II interferon | 1 |
| type II interferon-mediated signaling pathway | 1 |
| regulation of type II interferon-mediated signaling pathway | 1 |
| monoatomic cation transmembrane transport | 1 |
| transport | 1 |
| tissue development | 1 |
| animal organ development | 1 |
| monoatomic ion transport | 1 |
| transmembrane transport | 1 |
| ear morphogenesis | 1 |
| embryonic morphogenesis | 1 |
| inner ear development | 1 |
| monoatomic cation channel activity | 1 |
| proton transmembrane transporter activity | 1 |
| protein binding | 1 |
| membrane | 1 |
| cell periphery | 1 |
| actin filament bundle | 1 |
| actin-based cell projection | 1 |
Protein interactions and networks
STRING
616 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| OTOP1 | OC90 | Q02509 | 904 |
| OTOP1 | ATP2B2 | Q01814 | 759 |
| OTOP1 | PKD2L1 | Q9P0L9 | 718 |
| OTOP1 | ATP2B4 | P23634 | 703 |
| OTOP1 | SLC26A4 | O43511 | 661 |
| OTOP1 | TMEM128 | Q5BJH2 | 647 |
| OTOP1 | CALHM3 | Q86XJ0 | 626 |
| OTOP1 | OTOL1 | A6NHN0 | 622 |
| OTOP1 | CALHM1 | Q8IU99 | 609 |
| OTOP1 | TAS1R2 | Q8TE23 | 605 |
| OTOP1 | ELOVL3 | Q9HB03 | 573 |
| OTOP1 | PLCB2 | Q00722 | 572 |
| OTOP1 | TAS1R1 | Q7RTX1 | 541 |
| OTOP1 | CIDEA | O60543 | 525 |
| OTOP1 | COX7A1 | P24310 | 523 |
IntAct
2 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| OTOP1 | SEMG1 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (4): OTOP1 (Proximity Label-MS), SEMG2 (Affinity Capture-MS), SEMG1 (Affinity Capture-MS), OSBPL8 (Affinity Capture-MS)
ESM2 similar proteins: A2ARJ3, A2YD22, A5WVU6, A8X0L4, A9RA88, B0CMA4, F1QYC4, F1RAX4, G5EBX4, O17386, O22752, O22757, O22815, O59802, O80580, P28233, P51916, P93766, Q02739, Q05005, Q0DC45, Q0V947, Q19337, Q3UP23, Q5GH77, Q5R687, Q5RBT7, Q5U4Q2, Q5W0B7, Q5XV67, Q641M3, Q6NZ21, Q6PQZ3, Q6S5G4, Q6ZUK4, Q7M734, Q7RTM1, Q91WG1, Q921C1, Q94KB1
Diamond homologs: Q7M734, Q7RTM1, Q7RTS5, Q7RTS6, Q7ZWK8, Q80SX5, Q80UF9, Q80VM9, A9JTM7
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
120 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 1 |
| Likely pathogenic | 0 |
| Uncertain significance | 110 |
| Likely benign | 5 |
| Benign | 2 |
Top pathogenic / likely-pathogenic (1)
| Variant ID | HGVS | Classification |
|---|---|---|
| 3062781 | GRCh37/hg19 4p16.3-15.33(chr4:68345-14083766)x1 | Pathogenic |
SpliceAI
1063 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 4:4188969:CAAAG:C | acceptor_gain | 1.0000 |
| 4:4188974:C:CC | acceptor_gain | 1.0000 |
| 4:4188970:AAAG:A | acceptor_gain | 0.9900 |
| 4:4188971:AAG:A | acceptor_gain | 0.9900 |
| 4:4188972:AG:A | acceptor_gain | 0.9900 |
| 4:4188972:AGC:A | acceptor_loss | 0.9900 |
| 4:4188973:GC:G | acceptor_loss | 0.9900 |
| 4:4188974:C:CA | acceptor_loss | 0.9900 |
| 4:4188975:T:A | acceptor_loss | 0.9900 |
| 4:4202443:CT:C | donor_loss | 0.9900 |
| 4:4202447:C:CA | donor_loss | 0.9900 |
| 4:4202486:T:A | donor_gain | 0.9900 |
| 4:4202574:CAAAC:C | acceptor_gain | 0.9900 |
| 4:4202576:AAC:A | acceptor_gain | 0.9900 |
| 4:4202577:AC:A | acceptor_gain | 0.9900 |
| 4:4202578:CC:C | acceptor_gain | 0.9900 |
| 4:4202578:CCTG:C | acceptor_loss | 0.9900 |
| 4:4202579:C:A | acceptor_loss | 0.9900 |
| 4:4202579:C:CC | acceptor_gain | 0.9900 |
| 4:4226461:CCG:C | donor_gain | 0.9900 |
| 4:4226461:CCGCG:C | donor_gain | 0.9900 |
| 4:4226454:GGACT:G | donor_loss | 0.9800 |
| 4:4226455:GACTC:G | donor_loss | 0.9800 |
| 4:4226456:ACTC:A | donor_loss | 0.9800 |
| 4:4226457:CTCAC:C | donor_loss | 0.9800 |
| 4:4226458:TCA:T | donor_loss | 0.9800 |
| 4:4226459:CAC:C | donor_loss | 0.9800 |
| 4:4226460:A:AC | donor_gain | 0.9800 |
| 4:4226460:A:AG | donor_loss | 0.9800 |
| 4:4226461:C:CC | donor_gain | 0.9800 |
AlphaMissense
3954 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 4:4202538:A:G | W214R | 0.995 |
| 4:4202538:A:T | W214R | 0.995 |
| 4:4188895:A:G | W583R | 0.993 |
| 4:4188895:A:T | W583R | 0.993 |
| 4:4188970:A:G | W558R | 0.993 |
| 4:4188970:A:T | W558R | 0.993 |
| 4:4202548:G:C | N210K | 0.989 |
| 4:4202548:G:T | N210K | 0.989 |
| 4:4188902:A:C | F580L | 0.986 |
| 4:4188902:A:T | F580L | 0.986 |
| 4:4188904:A:G | F580L | 0.986 |
| 4:4226648:C:G | G73R | 0.986 |
| 4:4226648:C:T | G73R | 0.986 |
| 4:4226679:G:C | S62R | 0.985 |
| 4:4226679:G:T | S62R | 0.985 |
| 4:4226681:T:G | S62R | 0.985 |
| 4:4197172:A:C | N554K | 0.984 |
| 4:4197172:A:T | N554K | 0.984 |
| 4:4188893:C:A | W583C | 0.983 |
| 4:4188893:C:G | W583C | 0.983 |
| 4:4197969:A:G | W289R | 0.983 |
| 4:4197969:A:T | W289R | 0.983 |
| 4:4202546:A:G | L211P | 0.983 |
| 4:4226549:A:G | W106R | 0.983 |
| 4:4226549:A:T | W106R | 0.983 |
| 4:4188867:G:C | P592R | 0.982 |
| 4:4226668:C:T | G66E | 0.982 |
| 4:4202483:C:G | R232P | 0.981 |
| 4:4202514:A:G | S222P | 0.981 |
| 4:4188908:A:C | F578L | 0.980 |
dbSNP variants (sampled 300 via entrez): RS10000020 (4:4215724 A>G), RS1000044445 (4:4205069 G>A), RS10001663 (4:4217436 C>A), RS1000178118 (4:4216174 A>G), RS1000394203 (4:4204916 G>A), RS1000411037 (4:4188442 T>C), RS1000597820 (4:4209683 G>A), RS1000639505 (4:4225658 C>A), RS1000830477 (4:4198309 A>C), RS1001007591 (4:4203576 A>G), RS1001175376 (4:4204752 G>A,C), RS1001191203 (4:4215252 G>A,T), RS1001439103 (4:4210382 A>G), RS1001461372 (4:4203855 G>A), RS1001520984 (4:4193848 C>T)
Disease associations
OMIM: gene MIM:607806 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST009442_5 | Age-related cognitive decline (executive function) (slope of z-scores) | 4.000000e-06 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0007710 | cognitive decline measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
5 total (human), top 5 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Resveratrol | decreases expression, affects cotreatment | 1 |
| Arsenic | affects methylation | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
| Valproic Acid | decreases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.